Clinical presentations of parvovirus B19 infection

被引:2
|
作者
Servey, Jessica T.
Reamy, Brian V.
Hodge, Joshua
机构
[1] Family Med Clin, Travis AFB, CA 94535 USA
[2] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Although most persons with parvovirus B19 infection are asymptomatic or have mild, nonspecific, cold-like symptoms, several clinical conditions have been linked to the virus. Parvovirus B19 usually infects children and causes the classic "slapped-cheek" rash of erythema infectiosum (fifth disease). The virus is highly infectious and spreads mainly through respiratory droplets. By the time the rash appears, the virus is no longer infectious. The virus also may cause acute or persistent arthropathy and papular, purpuric eruptions on the hands and feet ("gloves and socks" syndrome) in adults. Parvovirus B19 infection can trigger an acute cessation of red blood cell production, causing transient aplastic crisis, chronic red cell aplasia, hydrops fetalis, or congenital anemia. This is even more likely in patients with illnesses that have already shortened the lifespan of erythrocytes (e.g., iron deficiency anemia, human immunodeficiency virus, sickle cell disease, thalassemia, spherocytosis). A clinical diagnosis can be made without laboratory confirmation if erythema infectiosum is present. If laboratory confirmation is needed, serum immunoglobulin M testing is recommended for immunocompetent patients; viral DNA testing is recommended for patients in aplastic crisis and for those who are immunocompromised. Treatment is usually supportive, although some patients may require transfusions or intravenous immune globulin therapy. Most patients recover completely.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [21] Parvovirus B19 infection and myofasciitis
    Ichinose, K
    Migita, K
    Sekita, T
    Hamada, H
    Ezaki, H
    Mukoubara, S
    Eguchi, K
    CLINICAL RHEUMATOLOGY, 2004, 23 (02) : 184 - 185
  • [22] Prenatal parvovirus B19 infection
    Kagan, Karl Oliver
    Hoopmann, Markus
    Geipel, Annegret
    Sonek, Jiri
    Enders, Martin
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (05) : 2363 - 2371
  • [23] Parvovirus B19 infection and myofasciitis
    Katsuhiro Ichinose
    Kiyoshi Migita
    Takaharu Sekita
    Hisayuki Hamada
    Hironori Ezaki
    Shigeaki Mukoubara
    Katsumi Eguchi
    Clinical Rheumatology, 2004, 23 : 184 - 185
  • [24] Parvovirus B19 infection in pregnancy
    de Jong, EP
    de Haan, TR
    Kroes, ACM
    Beersmab, MFC
    Oepkes, D
    Walther, FJ
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 (01) : 1 - 7
  • [25] LABORATORY INFECTION WITH PARVOVIRUS B19
    COHEN, BJ
    COUROUCE, AM
    SCHWARZ, TF
    OKOCHI, K
    KURTZMAN, GJ
    JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (09) : 1027 - 1028
  • [26] Parvovirus B19 infection and pregnancy
    Subtil, Damien
    Garabedian, Charles
    Chauvet, Agathe
    PRESSE MEDICALE, 2015, 44 (06): : 647 - 653
  • [27] CLINICAL PICTURE AND CONSEQUENCES OF FETAL PARVOVIRUS B19 INFECTION
    SHEIKH, AU
    ERNEST, JM
    ANNALS OF MEDICINE, 1995, 27 (01) : 7 - 8
  • [28] A clinical study of adult human parvovirus B19 infection
    Hayakawa, H
    Tara, M
    Niina, K
    Osame, M
    INTERNAL MEDICINE, 2002, 41 (04) : 295 - 299
  • [29] Basic and Clinical Aspects of Intrauterine Parvovirus B19 Infection
    K E Brown
    Pediatric Research, 1999, 45 : 771 - 771
  • [30] Uncommon clinical presentation of human parvovirus B19 infection
    Markoula, S.
    Giannopoulos, S.
    Argyropouiou, M.
    Sarmas, I.
    Konitsiotis, S.
    Maragoudaki, S.
    Kosmidou, M.
    Kyritsis, A. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 321 - 322